Drug ID: | NPD1772 |
Drug Name: | |
Molecular Formula: | C15H22N2O5 |
Canonical SMILES: | O/N=C(/c1ccc(cc1OC)OC)CN=C(OC(C)(C)C)O |
Standard InCHI: | InChI=1S/C15H22N2O5/c1-15(2,3)22-14(18)16-9-12(17-19)11-7-6-10(20-4)8-13(11)21-5/h6-8,19H,9H2,1-5H3,(H,16,18)/b17-12+ |
Standard InCHIKey: | FUHBRBIMEJUOSB-SFQUDFHCSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002087 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 16740558 |
ChEBI | |
CAS Number |
Molecular Weight | 310.15 |
ALogP | 0.9755 |
MLogP | 2.34 |
XLogP | 2.368 |
HDA | 3 |
HBD | 2 |
Rotatable Bonds | 14 |
TPSA | 92.87 |
RO5 Violation | 0 |